Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

3 Recession-Resistant Stocks: Low Beta, High Margins, Low Debt

Berdyansk, Ukraine - 4 June 2019: Regeneron Pharmaceuticals website homepage. Regeneron Pharmaceuticals logo visible on the phone screen, Illustrative Editorial. — Stock Editorial Photography

When thinking about stocks with recession-resistant characteristics, a few key metrics come to mind. First are low-beta stocks. Beta measures how much a stock’s price moves compared to the overall market. A beta of 1 means that, on average, when the market went up 10% in a month, the stock also went up 10%. Conversely, if the market went down 10%, so did the stock.

The stock market tends to fall in a recession. So, stocks with betas significantly less than one are likely to fall less than the market, raising the chance of outperformance. A negative beta is even better; it indicates that when the market falls, that stock tends to rise.

Second is strong operating margins. They show that the company can absorb a large decrease in revenue, which often happens in a recession, and remain profitable. I look for operating margins of over 20%.

Third is a low debt-to-equity (D/E) ratio. It’s a sign that a company isn’t overly financing its operations using debt. If revenues fall in a recession, companies with too much debt might struggle to pay their loans and bonds. Debt repayment is mandatory, meaning it's not a cost the company can cut when things get tough. Lower debt gives businesses more financial flexibility and means a lower risk of bankruptcy in a downturn. A D/E ratio below 50% is what I’ll use as a measuring stick.

Below are three stocks that meet these criteria. I’ll also provide return figures for the stocks that traded during the 2008 recession.

International Seaways: A Negative Beta Stock With a Huge Dividend Yield

International Seaways (NYSE: INSW) operates a fleet of oil tanker vessels that transport crude oil and petroleum products across the world by sea. One reason the company can have strong recession-resistance is due to the global importance of oil. Although the demand for oil drops significantly in a recession, it tends to drop less than the demand for other goods. Oil is vital for transport, heating, and electricity. People can't live without these, even in a downturn.

International Seaways has a five-year monthly beta of about -0.1. This implies that if the market goes down 10%, the company’s shares tend to rise 1%. It also has a robust operating margin of around 50%. Its D/E ratio is 39%. It's high compared to the other two firms on this list, but it's not glaring.

When things are going well, the company often issues supplemental dividends on top of its regular payments. Over the last twelve months, it has provided a dividend yield of over 13%.

Regeneron: A Low Beta, Low Debt, High Margin Business

Regeneron Pharmaceuticals (NASDAQ: REGN) is a huge biotech firm worth $89 billion. It ranks as the 16th largest public company in the biotech and pharma industries. Just like oil, drugs that significantly improve people’s lives are another thing they tend not to want to skimp on in a recession. Also, many people have insurance that covers their medications, so it’s not an expense that makes much sense to cut back on.

The company also has an extremely low beta, coming in at just over 0.1. Its operating margin provides a significant cushion with the number at 30% over the last twelve months (LTM). Its D/E ratio is also very low at just 9%, giving the company substantial flexibility in its cost structure if it needs to use it. The company’s return in 2008 was -24%. Although it might not look like much, that was 14% better than the S&P 500.

RLI’s Specialty Insurance Niche Provides Resistance Against a Downturn

RLI Corp. (NYSE: RLI) operates in the specialty insurance market. The types of insurance it provides are often difficult for those who want them to find. Because of this, policyholders are less likely to cancel their policies in a recession than other types of insurance. This also allows the company to achieve higher margins, as customers are willing to pay more to get the insurance they need.

Its D/E ratio is exceedingly low at 7%. Its LTM operating margin of 25% isn’t as spectacular as that of the other two firms. However, it is still above 88% of all US stocks, according to Koyfin. The company did extremely well in 2008, providing a total return of nearly 10%. Its beta is significantly higher than the other two stocks but is still much below one at 0.4.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.